Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Prieto

Showing results (581-590 of 657) with videos related to

Pageof 66
Sort By:
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 12, 2023
Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohortJ Machado-Rugolo, C M Baldavira, T G Prieto, et al.
The Journal of Investigative Dermatology|June 10, 2019
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma ProgressionShenying Fang, Tao Xu, Momiao Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanomaVictor G Prieto, Alexandra A Mourad-Zeidan, Vladislava Melnikova, et al.
Archives of Dermatological Research|April 22, 2016
Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitorsG S Falchook, P Rady, J C Konopinski, et al.
The American Journal of Dermatopathology|February 25, 2016
Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 CasesTawny Hung, Zsolt Argenyi, Lori Erickson, et al.
Journal of Cutaneous Pathology|May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinomaMario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
International Journal of Cancer|July 22, 2014
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasisSivan Izraely, Orit Sagi-Assif, Anat Klein, et al.
Journal of Cutaneous Pathology|June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesionsWei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Human Molecular Genetics|June 17, 1999
Allelic and locus heterogeneity in inherited venous malformationsJ T Calvert, T J Riney, C D Kontos, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|November 20, 2012
[Intestinal transplant: in what phase are we?]A M Andrés Moreno, E Ramos, F Hernández, et al.
Pageof 66

Showing results (581-590 of 657) with videos related to

Sort By:
Pageof 66
Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 12, 2023
Concomitant TP53 mutation in early-stage resected EGFR-mutated non-small cell lung cancer: a narrative approach in a genetically admixed Brazilian cohortJ Machado-Rugolo, C M Baldavira, T G Prieto, et al.
The Journal of Investigative Dermatology|June 10, 2019
Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma ProgressionShenying Fang, Tao Xu, Momiao Xiong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2006
Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanomaVictor G Prieto, Alexandra A Mourad-Zeidan, Vladislava Melnikova, et al.
Archives of Dermatological Research|April 22, 2016
Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitorsG S Falchook, P Rady, J C Konopinski, et al.
The American Journal of Dermatopathology|February 25, 2016
Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 CasesTawny Hung, Zsolt Argenyi, Lori Erickson, et al.
Journal of Cutaneous Pathology|May 13, 2020
Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinomaMario L Marques-Piubelli, Michael T Tetzlaff, Priyadharsini Nagarajan, et al.
International Journal of Cancer|July 22, 2014
The metastatic microenvironment: Claudin-1 suppresses the malignant phenotype of melanoma brain metastasisSivan Izraely, Orit Sagi-Assif, Anat Klein, et al.
Journal of Cutaneous Pathology|June 27, 2018
Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesionsWei-Shen Chen, Michael T Tetzlaff, Hafeez Diwan, et al.
Human Molecular Genetics|June 17, 1999
Allelic and locus heterogeneity in inherited venous malformationsJ T Calvert, T J Riney, C D Kontos, et al.
Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica|November 20, 2012
[Intestinal transplant: in what phase are we?]A M Andrés Moreno, E Ramos, F Hernández, et al.
Pageof 66